Market Capitalization of Balaxi Pharmaceuticals (BALAXI)
As of April 17, 2026, Balaxi Pharmaceuticals (BALAXI) market capitalisation is ₹132.44 Cr ($14.72M), with 5.02 Cr shares outstanding at a current price of ₹26.37 on NSE, ranking 2904 out of 5363 companies by market cap in our screener. Balaxi Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see BALAXI share price.
Market Cap History of Balaxi Pharmaceuticals (Last 10 Years)
BALAXI market capitalisation from year-end NSE closing prices over the last 10 years. Compare with BALAXI stock valuation models to assess whether the stock is under or overvalued.
End of Year Market Cap History — Balaxi Pharmaceuticals
BALAXI year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. View BALAXI 52-week performance for the annual high/low range and current price position.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹132.44 Cr
$14.72M USD
|
₹26.37 | NSE | -1.86% |
| 2025 |
₹134.95 Cr
$14.99M USD
|
₹26.87 | NSE | -62.84% |
| 2024 |
₹363.17 Cr
$40.35M USD
|
₹72.31 | NSE | -16.36% |
| 2023 |
₹434.18 Cr
$48.24M USD
|
₹86.45 | NSE | -28.82% |
| 2022 |
₹609.97 Cr
$67.77M USD
|
₹121.45 | NSE | +18.37% |
| 2021 |
₹515.30 Cr
$57.26M USD
|
₹102.60 | NSE | -21.08% |
| 2020 |
₹652.91 Cr
$72.55M USD
|
₹130.00 | NSE | +700.00% |
| 2019 |
₹81.61 Cr
$9.07M USD
|
₹16.25 | NSE | +185.09% |
| 2018 |
₹28.63 Cr
$3.18M USD
|
₹5.70 | NSE | +93.22% |
| 2017 |
₹14.82 Cr
$1.65M USD
|
₹2.95 | NSE | -13.24% |
| 2016 |
₹17.08 Cr
$1.90M USD
|
₹3.40 | NSE | -33.98% |
| 2015 |
₹25.87 Cr
$2.87M USD
|
₹5.15 | NSE | - |